美国核医学学会/美国心脏协会/美国超声心动图学会/欧洲核医学协会/美国心力衰竭协会/国际淀粉样变学会/心血管磁共振学会/核医学分子影像学会专家共识推荐：心脏淀粉样变多模态成像——第 2 部分：诊断标准和合理应用。
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization.
机构信息
Cardiac Amyloidosis Program, Cardiovascular Imaging Program, Departments of Radiology and Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
出版信息
J Card Fail. 2019 Nov;25(11):854-865. doi: 10.1016/j.cardfail.2019.08.002. Epub 2019 Aug 29.
Cardiac amyloidosis is emerging as an underdiagnosed cause of heart failure and mortality. Growing literature suggests that a noninvasive diagnosis of cardiac amyloidosis is now feasible. However, the diagnostic criteria and utilization of imaging in cardiac amyloidosis are not standardized. In this paper, Part 2 of a series, a panel of international experts from multiple societies define the diagnostic criteria for cardiac amyloidosis and appropriate utilization of echocardiography, cardiovascular magnetic resonance imaging, and radionuclide imaging in the evaluation of patients with known or suspected cardiac amyloidosis.
心脏淀粉样变正成为心力衰竭和死亡的一种未被充分诊断的病因。越来越多的文献表明，心脏淀粉样变现在可以通过非侵入性诊断。然而，心脏淀粉样变的诊断标准和影像学的应用尚未标准化。本文是系列文章的第 2 部分，由来自多个学会的一组国际专家定义了心脏淀粉样变的诊断标准以及在评估已知或疑似心脏淀粉样变患者时使用超声心动图、心血管磁共振成像和放射性核素成像的适当方法。
Zotero 插件